By restoring the NO/ONOO− balance and preventing the progression of atherosclerosis, statins activate eNOS, increase NO bioavailability, reduce the release of ONOO− from the endothelium, and increase HO-1 expression and total HO activity [81]. This evidence concerns the gene HMOX1 and atherosclerosis.